These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 9849146)
61. Tests for genetic heterogeneity among 18 families with Alzheimer's disease. Marazita ML; Spence MA; Heyman A Neurology; 1987 Oct; 37(10):1678-9. PubMed ID: 2958722 [TBL] [Abstract][Full Text] [Related]
62. Down's syndrome and Alzheimer's disease: towards secondary prevention. Ness S; Rafii M; Aisen P; Krams M; Silverman W; Manji H Nat Rev Drug Discov; 2012 Sep; 11(9):655-6. PubMed ID: 22935789 [TBL] [Abstract][Full Text] [Related]
63. Younger-onset Alzheimer's disease: learning from the experience of one spouse carer. Williams O; Keady J; Nolan M J Clin Nurs; 1995 Jan; 4(1):31-6. PubMed ID: 7704373 [TBL] [Abstract][Full Text] [Related]
64. Are there clinical differences between familial and nonfamilial Alzheimer's disease? Luchins DJ; Cohen D; Hanrahan P; Eisdorfer C; Paveza G; Ashford JW; Gorelick P; Hirschman R; Freels S; Levy P Am J Psychiatry; 1992 Aug; 149(8):1023-7. PubMed ID: 1386194 [TBL] [Abstract][Full Text] [Related]
65. [Roles of miR-155 microRNA in dementia associated with Down's syndrome]. Nuovo G; Tili E; Awad H; Michaille JJ Med Sci (Paris); 2018 Nov; 34(11):922-924. PubMed ID: 30526830 [No Abstract] [Full Text] [Related]
66. The dementia of Down's syndrome and its relevance to aetiological studies of Alzheimer's disease. Whalley LJ Ann N Y Acad Sci; 1982; 396():39-53. PubMed ID: 6217776 [No Abstract] [Full Text] [Related]
73. Down's syndrome, longevity, and Alzheimer's disease. Harrison P Br J Psychiatry; 1993 Feb; 162():276. PubMed ID: 8435713 [No Abstract] [Full Text] [Related]
74. Intersectin 1 contributes to phenotypes in vivo: implications for Down's syndrome. Hunter MP; Nelson M; Kurzer M; Wang X; Kryscio RJ; Head E; Pinna G; O'Bryan JP Neuroreport; 2011 Oct; 22(15):767-72. PubMed ID: 21876463 [TBL] [Abstract][Full Text] [Related]
75. Familial aggregation of Alzheimer's disease and related disorders: a collaborative re-analysis of case-control studies. van Duijn CM; Clayton D; Chandra V; Fratiglioni L; Graves AB; Heyman A; Jorm AF; Kokmen E; Kondo K; Mortimer JA; Rocca WA; Shalat SL; Soininen H; Hofman A; Int J Epidemiol; 1991; 20 Suppl 2():S13-20. PubMed ID: 1833349 [TBL] [Abstract][Full Text] [Related]
76. Alzheimer's disease in people with Down's syndrome: the prospects for and the challenges of developing preventative treatments. Castro P; Zaman S; Holland A J Neurol; 2017 Apr; 264(4):804-813. PubMed ID: 27778163 [TBL] [Abstract][Full Text] [Related]
77. Apolipoprotein E, Alzheimer's disease and Down's syndrome. Prasher VP; Haque MS Br J Psychiatry; 2000 Nov; 177():469-70. PubMed ID: 11060007 [No Abstract] [Full Text] [Related]
78. [Cognition in Down's Syndrome: Development across the Life Span and Neuropsychological Assessment in Adults]. Loosli SV; Schmidt L; NĂ¼bling G; Wlasich E; Prix C; Danek A; Levin J Fortschr Neurol Psychiatr; 2021 Sep; 89(9):433-444. PubMed ID: 33647991 [TBL] [Abstract][Full Text] [Related]
79. A study of digestive absorption in four cases of Down's syndrome. Down's syndrome, malnutrition, malabsorption, and Alzheimer's disease. Abalan F; Jouan A; Weerts MT; Solles C; Brus J; Sauneron MF Med Hypotheses; 1990 Jan; 31(1):35-8. PubMed ID: 2138242 [TBL] [Abstract][Full Text] [Related]